Correlation Between Cullinan Oncology and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Kalvista Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Kalvista Pharmaceuticals
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cullinan and Kalvista is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Kalvista Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 1.67 times less risky than Kalvista Pharmaceuticals. The stock trades about -0.64 of its potential returns per unit of risk. The Kalvista Pharmaceuticals is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 877.00 in Kalvista Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 209.00 from holding Kalvista Pharmaceuticals or generate 23.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cullinan Oncology LLC vs. Kalvista Pharmaceuticals
Performance |
Timeline |
Cullinan Oncology LLC |
Kalvista Pharmaceuticals |
Cullinan Oncology and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cullinan Oncology and Kalvista Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.Cullinan Oncology vs. Bolt Biotherapeutics | ||
Cullinan Oncology vs. Day One Biopharmaceuticals | ||
Cullinan Oncology vs. Lyra Therapeutics | ||
Cullinan Oncology vs. Autolus Therapeutics |
Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | ||
Kalvista Pharmaceuticals vs. Kura Oncology | ||
Kalvista Pharmaceuticals vs. Viridian Therapeutics | ||
Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |